المؤلفون: Adiels, Martin, 1976, Chapman, M. J., Robillard, P., Krempf, M., Laville, M., Borén, Jan, 1963, Niacin Study, Grp

المصدر: Journal of Clinical Lipidology. 12(3):810-821

مصطلحات موضوعية: Clinical Medicine, Klinisk medicin, ER niacin, Mixed dyslipidemia, Metabolic syndrome, Triglyceride, LDL, HDL, Inflammation, Insulin resistance, Interleukin-6, Apolipoprotein CIII, extended-release niacin, type-2 diabetes-mellitus, apolipoprotein-a-i, nicotinic-acid, cardiovascular-disease, insulin-resistance, adipose-tissue, hepg2 cells, high-risk, adiponectin, Pharmacology & Pharmacy

URL الوصول: https://gup.ub.gu.se/publication/269087

المؤلفون: Adiels, Martin, Chapman, M John, Robillard, Paul, Krempf, Michel, Laville, Martine, Borén, Jan, Niacin Study Group, .

المساهمون: Hôpital Guillaume et René Laennec - Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), University of Gothenburg (GU), Dyslipidémies, inflammation et athérosclérose dans les maladies métaboliques, Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie des Adaptations Nutritionnelles (PhAN), Université de Nantes (UN)-Institut National de la Recherche Agronomique (INRA), Mécanisme Moléculaire du Diabète (MMD), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), GlaxoSmithKline (Les Ulis, France), Randox Laboratories (Crumlin, N. Ireland), Sahlgrenska University Hospital ALF Research Grants, National Institute for Health and Medical Research, ARLA (Association for Research on Lipoproteins and Atherogenesis), Randox Laboratories, Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Recherche Agronomique (INRA)-Université de Nantes (UN), ProdInra, Migration

المصدر: Journal of clinical lipidology
Journal of clinical lipidology, Elsevier, 2018, 12 (3), pp.810--821
Journal of clinical lipidology, Elsevier, 2018, 12 (3), pp.810-821.e1. ⟨10.1016/j.jacl.2018.03.083⟩

مصطلحات موضوعية: Male, HDL, [SDV]Life Sciences [q-bio], cardiovascular-disease, adipose-tissue, Triglyceride, Niacin, insulin-resistance, LDL, hepg2 cells, high-risk, Apolipoprotein CIII, Mixed dyslipidemia, Humans, Pharmacology & Pharmacy, ER niacin, Blood Coagulation, nicotinic-acid, Dyslipidemias, Inflammation, Metabolic Syndrome, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, adiponectin, Interleukin-6, Macrophages, extended-release niacin, Middle Aged, Apolipoprotein, [SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, apolipoprotein-a-i, Phenotype, Liver, lipids (amino acids, peptides, and proteins), type-2 diabetes-mellitus, Insulin Resistance, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, CIII, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::19f360d92b4bcff0e78d444ae78d5904
https://pubmed.ncbi.nlm.nih.gov/29753732

المؤلفون: Ulf Landmesser

المساهمون: University of Zurich, Landmesser, Ulf

المصدر: European Heart Journal

مصطلحات موضوعية: Male, Vitamin, Drug, medicine.medical_specialty, Indoles, Statin, medicine.drug_class, media_common.quotation_subject, Arterial Occlusive Diseases, 610 Medicine & health, Placebo, Niacin, 2705 Cardiology and Cardiovascular Medicine, 10052 Institute of Physiology, chemistry.chemical_compound, Muscular Diseases, cardiovascular disease, Internal medicine, medicine, Clinical endpoint, Humans, LDL-cholesterol, Myocardial infarction, Hypolipidemic Agents, media_common, business.industry, ER niacin/laropiprant, nutritional and metabolic diseases, medicine.disease, Fasttrack Clinical, HDL-cholesterol, Surgery, chemistry, 10209 Clinic for Cardiology, 570 Life sciences, biology, Female, Chemical and Drug Induced Liver Injury, Cardiology and Cardiovascular Medicine, business, Laropiprant, secondary prevention

وصف الملف: Editorial_HPS2-THRIVE_Trial.pdf - application/pdf; eht064.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c6eea334fc5177a7898661db3974e2
https://doi.org/10.1093/eurheartj/eht064

المؤلفون: Kim Engler, Réjean Thomas, Gina M Graziani, Bertrand Lebouché, Marie-Josée Brouillette, Joel Singer, Jean-Pierre Routy, Benoit Trottier, Mohammad-Ali Jenabian

المصدر: Trials

مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Time Factors, Anti-HIV Agents, Medicine (miscellaneous), Inflammation, HIV Infections, CD38, CD8-Positive T-Lymphocytes, Lymphocyte Activation, Niacin, law.invention, Antiretroviral therapy (ART), T-cell immune activation, Study Protocol, Immune system, Cognition, Randomized controlled trial, Acquired immunodeficiency syndrome (AIDS), Clinical Protocols, law, Medicine, Humans, Pharmacology (medical), Disease progression, Tryptophan (Trp), Cross-Over Studies, Membrane Glycoproteins, business.industry, Quebec, Human immunodeficiency virus (HIV-1), HLA-DR Antigens, medicine.disease, Crossover study, ADP-ribosyl Cyclase 1, CD4 Lymphocyte Count, Vitamin B3, Treatment Outcome, Research Design, Delayed-Action Preparations, Immunology, HIV-1, medicine.symptom, Extended-release (ER) niacin, business, Neurocognitive

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2cb14d5199ed64572f92906e562b41
https://pubmed.ncbi.nlm.nih.gov/25293882

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

مؤلفون مشاركون: HPS2-THRIVE Collaborative Group; Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK. thrive@ctsu.ox.ac.uk

المصدر: European heart journal [Eur Heart J] 2013 May; Vol. 34 (17), pp. 1279-91. Date of Electronic Publication: 2013 Feb 26.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Arterial Occlusive Diseases/*drug therapy , Chemical and Drug Induced Liver Injury/*etiology , Hypolipidemic Agents/*administration & dosage , Indoles/*administration & dosage , Muscular Diseases/*chemically induced , Niacin/*administration & dosage, Death, Sudden, Cardiac/prevention & control ; Delayed-Action Preparations ; Drug Therapy, Combination ; Female ; Humans ; Hypolipidemic Agents/adverse effects ; Indoles/adverse effects ; Male ; Middle Aged ; Myocardial Infarction/prevention & control ; Myocardial Reperfusion/statistics & numerical data ; Niacin/adverse effects ; Simvastatin/administration & dosage ; Stroke/prevention & control